跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Latoprost - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Latoprost
Approved
STANDARD
Latoprost
Sun Pharmaceutical Medicare Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
51ef7a44fef73dad
Company
Sun Pharmaceutical Medicare Limited
Type
Standard
Approval Details
Approval Id
51ef7a44fef73dad
Drug Approval Philippines Name
Latoprost
Product Name
Latoprost
Registration Number
DRP-8607
Brand Name
Latoprost
Generic Name
Latanoprost
Dosage Form
Ophthalmic Solution
Dosage Strength
50 mcg/mL (0.005% w/v))
Manufacturer
Sun Pharmaceutical Medicare Limited
Importer
Sun Pharma Philippines, Inc.
Distributor
Sun Pharma Philippines, Inc.
Company Detail Path
/organization/sun-pharmaceutical-medicare-limited
Issuance Date
03 October 2022
Expiry Date
11 April 2028
Pharmacologic Category
Antiglaucoma (Prostaglandin Analogue)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
51ef7a44fef73dad
Type
Standard
Back to Philippines FDA Approvals